Delving into the Latest Updates on Zhongshan Zunlong Pharmaceutical Co. Ltd. with Synapse

Overview

The bioequivalence of gliclazide sustained-release tablets produced by Guangdong Shangruihe Pharmaceutical Co., Ltd. and the reference preparation (gliclazide sustained-release tablets produced by Servier (Tianjin) Pharmaceutical Co., Ltd., trade name: Damecon) was studied on healthy male volunteers to provide a basis for drug registration and rational clinical drug use.

Start Date08 Sep 2012

Sponsor / Collaborator

Zhongshan Zunlong Pharmaceutical Co. Ltd.

CTR20131744

/ Not yet recruiting

格列喹酮分散片人体生物等效性研究

[Translation] Study on the bioequivalence of gliquidone dispersible tablets in healthy volunteers

以北京万辉双鹤药业有限责任公司生产的格列喹酮片（糖适平）为参比制剂，研究广东尚瑞和药业股份有限公司研制的格列喹酮分散片在健康受试者的人体生物等效性。

[Translation]

The bioequivalence of gliquidone dispersible tablets developed by Guangdong Shangruihe Pharmaceutical Co., Ltd. in healthy subjects was studied using gliquidone tablets (Tangshiping) produced by Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. as the reference preparation.

Start Date-

Sponsor / Collaborator

Zhongshan Zunlong Pharmaceutical Co. Ltd.

100 Clinical Results associated with Zhongshan Zunlong Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Zhongshan Zunlong Pharmaceutical Co. Ltd.

Login to view more data

100 Deals associated with Zhongshan Zunlong Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Zhongshan Zunlong Pharmaceutical Co. Ltd.

Login to view more data